Health
About 1.8 million Americans received COVID injections last week
About 1.8 million Americans received the COVID-19 vaccine in the week ending 22 September, according to data compiled by health data and analytics firm IQVIA
Johnson & Johnson urged to improve access to tuberculosis drug
Global health aid agency Unitaid has written to Johnson & Johnson CEO Joaquin Duato, urging him to take “immediate action” to expand access to the
German court suspends mRNA patent proceedings against BioNTech
A German court on Thursday suspended patent proceedings against BioNTech over the use of mRNA technology in a COVID-19 vaccine developed by the German company
Gritstone wins $433 million contract to research a vaccine against COVID
The US government has awarded Gritstone Biography a $433 million contract to conduct an interim study of a self-amplifying mRNA vaccine candidate against COVID-19. The
RCL Foods has destroyed 410,000 chickens due to an outbreak of bird flu
South Africa’s RCL Foods said on Thursday its Rainbow poultry division had slaughtered 410,000 chickens due to the country’s worst-ever bird flu outbreak, fuelling fears
The UK’s first supervised drug injection site has been approved
The UK’s first formal controlled drug consumption room was approved on Wednesday to reduce infectious diseases and overdoses in Scotland, which suffers the highest rate
Cough syrup deaths have led to tougher toxicity testing measures in the US
The US FDA is cracking down on lax testing practices by dozens of health product makers after hundreds of deaths overseas from contaminated cough syrups,
McKinsey to pay $230 million in compensation for opioids in the US
Consulting firm McKinsey & Co has agreed to pay $230 million to settle lawsuits by hundreds of local governments and school districts in the US
Japan has approved Eisai and Biogen’s Leqembi treatment for Alzheimer’s disease
Japanese company Eisai has announced that its Alzheimer’s disease treatment developed with Biogen, Leqembi, has been approved by the country’s Ministry of Health, making it
Novartis confirms the spin-off of Sandoz on 4 October 2023
Novartis on Monday confirmed its plans for a 100% spin-off of its Sandoz business on 4 October after shareholders gave their approval earlier this month.